Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the United States Edaravone market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Edaravone in these regions, from 2018 to 2025 (forecast).
United States Edaravone market competition by top manufacturers/players, with Edaravone sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Mitsubishi Tanabe Pharma
Simcere
Taj Pharmaceuticals Ltd.
Sun Pharmaceutical Industries Ltd.
Unichem Laboratories Ltd
UCB India Ltd
Piramal Healthcare
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Oral
Injection
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Edaravone for each application, including
Hospital
Clinic
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Edaravone Market Report 2019
1 Edaravone Overview
1.1 Product Overview and Scope of Edaravone
1.2 Classification of Edaravone by Product Category
1.2.1 United States Edaravone Market Size (Sales Volume) Comparison by Type (2014-2024)
1.2.2 United States Edaravone Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Oral
1.2.4 Injection
1.3 United States Edaravone Market by Application/End Users
1.3.1 United States Edaravone Market Size (Consumption) and Market Share Comparison by Application (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 United States Edaravone Market by Region
1.4.1 United States Edaravone Market Size (Value) Comparison by Region (2014-2024)
1.4.2 The West Edaravone Status and Prospect (2014-2024)
1.4.3 Southwest Edaravone Status and Prospect (2014-2024)
1.4.4 The Middle Atlantic Edaravone Status and Prospect (2014-2024)
1.4.5 New England Edaravone Status and Prospect (2014-2024)
1.4.6 The South Edaravone Status and Prospect (2014-2024)
1.4.7 The Midwest Edaravone Status and Prospect (2014-2024)
1.5 United States Market Size (Value and Volume) of Edaravone (2014-2024)
1.5.1 United States Edaravone Sales and Growth Rate (2014-2024)
1.5.2 United States Edaravone Revenue and Growth Rate (2014-2024)
2 United States Edaravone Market Competition by Players/Suppliers
2.1 United States Edaravone Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Edaravone Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Edaravone Average Price by Players/Suppliers (2014-2019)
2.4 United States Edaravone Market Competitive Situation and Trends
2.4.1 United States Edaravone Market Concentration Rate
2.4.2 United States Edaravone Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Edaravone Manufacturing Base Distribution, Sales Area, Product Type
3 United States Edaravone Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Edaravone Sales and Market Share by Region (2014-2019)
3.2 United States Edaravone Revenue and Market Share by Region (2014-2019)
3.3 United States Edaravone Price by Region (2014-2019)
4 United States Edaravone Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Edaravone Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Edaravone Revenue and Market Share by Type (2014-2019)
4.3 United States Edaravone Price by Type (2014-2019)
4.4 United States Edaravone Sales Growth Rate by Type (2014-2019)
5 United States Edaravone Sales (Volume) by Application (2014-2019)
5.1 United States Edaravone Sales and Market Share by Application (2014-2019)
5.2 United States Edaravone Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States Edaravone Players/Suppliers Profiles and Sales Data
6.1 Mitsubishi Tanabe Pharma
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Edaravone Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Mitsubishi Tanabe Pharma Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Simcere
6.2.2 Edaravone Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Simcere Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Taj Pharmaceuticals Ltd.
6.3.2 Edaravone Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Taj Pharmaceuticals Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Sun Pharmaceutical Industries Ltd.
6.4.2 Edaravone Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sun Pharmaceutical Industries Ltd. Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Unichem Laboratories Ltd
6.5.2 Edaravone Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Unichem Laboratories Ltd Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 UCB India Ltd
6.6.2 Edaravone Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 UCB India Ltd Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Piramal Healthcare
6.7.2 Edaravone Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Piramal Healthcare Edaravone Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
...
7 Edaravone Manufacturing Cost Analysis
7.1 Edaravone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Edaravone
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Edaravone Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Edaravone Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Edaravone Market Size (Value and Volume) Forecast (2019-2024)
11.1 United States Edaravone Sales Volume, Revenue Forecast (2019-2024)
11.2 United States Edaravone Sales Volume Forecast by Type (2019-2024)
11.3 United States Edaravone Sales Volume Forecast by Application (2019-2024)
11.4 United States Edaravone Sales Volume Forecast by Region (2019-2024)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
